Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Metagenomi (MGX) Net Margin (2023 - 2025)

Metagenomi (MGX) has disclosed Net Margin for 3 consecutive years, with 576.02% as the latest value for Q4 2025.

  • Quarterly Net Margin fell 33264.0% to 576.02% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 348.54% through Dec 2025, down 19928.0% year-over-year, with the annual reading at 348.54% for FY2025, 19928.0% down from the prior year.
  • Net Margin for Q4 2025 was 576.02% at Metagenomi, down from 235.51% in the prior quarter.
  • The five-year high for Net Margin was 53.67% in Q2 2024, with the low at 606.71% in Q1 2025.
  • Average Net Margin over 3 years is 246.21%, with a median of 205.86% recorded in 2023.
  • The sharpest move saw Net Margin soared 6107bps in 2024, then plummeted -38135bps in 2025.
  • Over 3 years, Net Margin stood at 155.61% in 2023, then plummeted by -56bps to 243.37% in 2024, then plummeted by -137bps to 576.02% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 576.02%, 235.51%, and 233.85% for Q4 2025, Q3 2025, and Q2 2025 respectively.